Post Profile

Use Of Genetic Information May Help Predict Likelihood Of Survival Following Chemotherapy For Breast Cancer

Development of a predictive test that included genomic signatures that indicated chemoresistance, chemosensitivity and endocrine sensitivity for women with newly diagnosed breast cancer identified patients with a high probability of survival following chemotherapy, according to a study in the May 11 issue of JAMA. Identification of patients with high likelihood of survival following a standard chemotherapy regimen (and then endocrine therapy, if estrogen receptor [ER]-positive) would reaffirm a treatment decision regarding the use of chemotherapy.
read more


Related Posts

Genes In Healthy Breast Tissue May Predict Who Will Benefit From Drugs To Prevent Estrogen-Sensitive Breast Cancer

Health : Medical News Today

A newly identified set of genes may predict which women are at high risk for getting breast cancer that is sensitive to estrogen and, therefore, would be helped by taking drugs to prevent it, reports a new Northwestern Medicine stud...

How to Identify Drugs That Work Best for Each Patient

Health : Newswise Medical News

More than 100 drugs have been approved to treat cancer, but predicting which ones will help a particular patient is an inexact science at best. A new implantable device developed at MIT may change that.

A Frequent Genomic Alteration Is Identified in a Rare Subset of Breast Cancer

Health : Newswise Medical News

Research from Rutgers Cancer Institute of New Jersey shows genomic profiling identifies genomic mutations in a gene associated with a rare subset of breast cancer - mutations that cannot otherwise be identified with standard clinica...

Some Breast Cancer Patients Spared Chemotherapy By New Genomic Test

Health : Medical News Today

Testing a breast cancer tumour for its genomic signature can help identify which patients will need adjuvant systemic therapy (additional chemotherapy) after surgery, and spare its use in those for whom it is not necessary, accordin...

Genomic Test Shows Promise As Predictor Of Chemotherapy Response, Survival For Women With Invasive Breast Cancer

Health : Medical News Today

A new genomic test combining multiple signatures a patient's estrogen receptor status, endocrine therapy response, chemotherapy resistance and sensitivity shows promise as a predictor of chemotherapy response and survival benefit in...


Copyright © 2015 Regator, LLC